COMMUNIQUÉS West-GlobeNewswire

Admera Health Adds Clinical Genomics Expert, Dr. Ruben Bonilla-Guerrero, to Management Team

04/12/2018 - 15:13

SOUTH PLAINFIELD, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Admera Health, a molecular diagnostic company, welcomes Dr. Ruben Bonilla-Guerrero as Medical Director to the company. Ruben Bonilla-Guerrero obtained his M.D. [...]

New Proximity Systems Open-Arm Cabinet Meets Space Constraints of Shrinking Patient Rooms

04/12/2018 - 15:00

Flexible workstation mount is ergonomically designed to improve ability of hospital staff to interact with patients TOMBALL, Texas, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Proximity Systems, Inc., the leading provider of [...]

Cellectar Initiates Cohort 6 of Phase 1b Trial Evaluating CLR 131 in Relapsed/Refractory Multiple Myeloma

04/12/2018 - 14:30

Patient enrolled at highest fractionated two-dose regimen to date FLORHAM PARK, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]

Ritter Pharmaceuticals Reaches Halfway Mark for Enrollment in Pivotal Phase 3 Clinical Trial of RP-G28 in Patients with Lactose Intolerance

04/12/2018 - 14:30

Full Enrollment on Target for Q2 2019 with Data Readout Expected in the Second Half of 2019 LOS ANGELES, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “ [...]

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

04/12/2018 - 14:30

BRIDGEWATER, N.J., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced [...]

PSIQ Grants Exclusive Distribution Rights for Mexico and Argentina With First Year Minimum Guarantee of $500,000 and 20% Growth Per Year Thereafter

04/12/2018 - 14:30

SUNRISE, Fla., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announces it has granted the exclusive distribution rights for Mexico and Argentina to RCS International Investments, Corp. (“RCS [...]

XBiotech annonce la réussite de l'audit BPF

04/12/2018 - 14:18

Le premier audit dans la nouvelle usine de fabrication de la société montre sa conformité aux directives BPF AUSTIN, Texas, 04 déc. 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) a annoncé aujourd'hui le succès de [...]

Orion acquires sales and distribution rights for certain European Countries for Parkinson's disease drug Stalevo

04/12/2018 - 14:01

ORION CORPORATION PRESS RELEASE 4 DECEMBER 2018 at 15.00 EET Orion acquires sales and distribution rights for certain European Countries for Parkinson's disease drug Stalevo Orion Corporation and Novartis Pharma AG have [...]

HempAmericana Upgrades CBD Quality and Output Capacity at Primary Facility Ahead of Full-Scale Production

04/12/2018 - 14:00

NEW YORK, Dec. 04, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE – HempAmericana, Inc. (OTC: HMPQ) (“HempAmericana” or the “Company”) is excited to announce the installation of a new high-precision Solvent Recovery Machine [...]

Director/PDMR Shareholding

04/12/2018 - 14:00

DXS INTERNATIONAL PLC Director Dealing The Board of DXS International plc (the “Company”), the NEX quoted clinical decision support developer and supplier of clinical decision support systems is pleased to confirm that [...]

Inovio Announces Initiation of “MD Anderson’s HPV-Related Cancers Moon Shot” Phase 2 Trial in New HPV Indications

04/12/2018 - 14:00

Phase 2 cancer study will evaluate T cell-activating immunotherapy MEDI0457 with MedImmune’s durvalumab targeting several HPV-related cancers PLYMOUTH MEETING, Pa., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Inovio [...]

Nemaura Successfully Completes Clinical Studies for SugarBEAT® FDA De-Novo 510(k) Submission

04/12/2018 - 14:00

LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive affordable and flexible Continuous Glucose Monitor (CGM) for use by people with diabetes [...]

AzurRx BioPharma to Present at Upcoming Investor Conferences

04/12/2018 - 14:00

BROOKLYN, N.Y., Dec. 04, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]

Interface Biologics Announces New V.P., Business Development

04/12/2018 - 14:00

TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- Interface Biologics Inc. (“IBI”), a privately held, commercial stage developer of innovative material science technologies for Medtech and Pharmaceutical applications, is [...]

Biotricity Actively Pursues Holter Market with Bioflux Product Offering

04/12/2018 - 14:00

Company Leverages Connectivity-Enabled Holter Capability to Expand Market Reach REDWOOD CITY, Calif., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Biotricity Inc. (OTCQB : BTCY ), a medical diagnostic and consumer healthcare [...]

NexImmune Completes Sr. Leadership Team with New VP Hires

04/12/2018 - 14:00

Naimish Pandya, MD assumes role of VP & Head, Clinical Development Alex Matschiner, MS ChE assumes role of VP, Protein Process Development GAITHERSBURG, Md., Dec. 04, 2018 (GLOBE NEWSWIRE) -- NexImmune, an emerging [...]

Media Advisory: Canadian Blood Services board meeting open to the public

04/12/2018 - 14:00

OTTAWA, Dec. 04, 2018 (GLOBE NEWSWIRE) -- On December 6, Canadian Blood Services will open its doors physically and virtually, by live streaming its open board meeting at blood.ca, and inviting the public to attend in [...]

Avis aux médias : Le conseil d’administration de la Société canadienne du sang ouvre sa prochaine réunion au public

04/12/2018 - 14:00

OTTAWA, 04 déc. 2018 (GLOBE NEWSWIRE) -- La Société canadienne du sang invite la population à assister, en personne ou en ligne, à la réunion du conseil d’administration qui aura lieu au siège social de l’organisation, [...]

BioSyent Announces Normal Course Issuer Bid

04/12/2018 - 14:00

TORONTO, Dec. 04, 2018 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that the TSX Venture Exchange (“TSX-V”) has accepted the Company’s Notice of Intention to Make [...]